Evidence map›Paper›PMID 26637399›Full record

ArticleGene expression2015

The Histone Acetyltransferase GCN5 Expression Is Elevated and Regulated by c-Myc and E2F1 Transcription Factors in Human Colon Cancer.

Yan-Wei Yin, Hong-Jian Jin, Wenjing Zhao, Beixue Gao, Jiangao Fang, Junmin Wei, Donna D Zhang, Jianing Zhang, Deyu Fang

Open access · hybridAbstract read
In one paragraph

Article in Gene expression, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Integrative analysis of histone acetyltransferase KAT2A in human cancer.Cancer biomarkers : section A of Disease markers · 2023
    Article
  12. Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A.Journal of enzyme inhibition and medicinal chemistry · 2022
    Article
  13. Genes · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Complex functions of Gcn5 and Pcaf in development and disease.Biochimica et biophysica acta. Gene regulatory mechanisms · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Yan-Wei YinDepartment of Oncology, Linyi People's Hospital, and Linyi Tumor Hospital, Linyi, P.R. China.
Hong-Jian Jin
Wenjing Zhao
Beixue Gao
Jiangao Fang
Junmin Wei
Donna D Zhang
Jianing Zhang
Deyu Fang
Dalian University of Technology · CNInstitute of Pharmacology · CZLinyi People's Hospital · CNShandong University · CN

Funding

Investigation of an anti-cancer phytochemical targeting Nrf2R01CA154377 · NCI · UNIVERSITY OF ARIZONA · PI ZHANG, DONNA D · 2011 to 2015
$1.5M
NCI NIH HHS R01 CA154377
6 · The paper itself

Abstract

The histone acetyltransferase GCN5 has been suggested to be involved in promoting cancer cell growth. But its role in human colon cancer development remains unknown. Herein we discovered that GCN5 expression is significantly upregulated in human colon adenocarcinoma tissues. We further demonstrate that GCN5 is upregulated in human colon cancer at the mRNA level. Surprisingly, two transcription factors, the oncogenic c-Myc and the proapoptotic E2F1, are responsible for GCN5 mRNA transcription. Knockdown of c-Myc inhibited colon cancer cell proliferation largely through downregulating GCN5 transcription, which can be fully rescued by the ectopic GCN5 expression. In contrast, E2F1 expression induced human colon cancer cell death, and suppression of GCN5 expression in cells with E2F1 overexpression further facilitated cell apoptosis, suggesting that GCN5 expression is induced by E2F1 as a possible negative feedback in suppressing E2F1-mediated cell apoptosis. In addition, suppression of GCN5 with its specific inhibitor CPTH2 inhibited human colon cancer cell growth. Our studies reveal that GCN5 plays a positive role in human colon cancer development, and its suppression holds a great therapeutic potential in antitumor therapy.

Indexed as

Colonic NeoplasmsE2F1 Transcription FactorHumansInfantp300-CBP-Associated Factorp300-CBP Transcription FactorsProto-Oncogene Proteins c-mycRNA, MessengerE2F1 Transcription Factorp300-CBP-Associated Factorp300-CBP Transcription FactorsProto-Oncogene Proteins c-mycRNA, Messenger

Identifiers

PMID26637399
PMCPMC5584536
OpenAlexW2292490918

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.